Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.

^*Corresponding author for this work

Research output: Contribution to journal › Review

27 Citations (Web of Science)

Original language	English
Journal	Current Pharmaceutical Design
DOIs	https://doi.org/10.2174/13816128113199990342
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{16a3edfc82a2418bb4e1908e961521ee,

title = "Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.",

author = "Martin H{\"o}nigl and Robert Krause",

year = "2013",

doi = "10.2174/13816128113199990342",

language = "English",

journal = "Current Pharmaceutical Design",

issn = "1381-6128",

publisher = "Bentham Science Publishers",

}

TY - JOUR

T1 - Antifungal therapy of aspergillosis of the central nervous system and aspergillus endophthalmitis.

A2 - Hönigl, Martin

A2 - Krause, Robert

PY - 2013

Y1 - 2013

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000318157700007

UR - https://pubmed.ncbi.nlm.nih.gov/23278539

U2 - 10.2174/13816128113199990342

DO - 10.2174/13816128113199990342

M3 - Review

C2 - 23278539

SN - 1381-6128

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

ER -